Eurosurveillance aims to be the authoritative and representative public health voice of the communicable disease community in Europe and beyond. Our main focus is on Europe, and authors from other parts of the world are encouraged to submit articles, provided that they add value to a European audience.

Our main objectives are to:

provide facts and guidance for health professionals and decision-makers to facilitate the implementation of effective prevention and control measures;

support the preparedness and response to health threats in Europe through the rapid dissemination of high-quality authoritative scientific information on relevant outbreaks or emergency situations;

provide a European-specific platform for health professionals to share scientific findings in infectious disease epidemiology, prevention and control;

disseminate surveillance data on communicable diseases and publish analyses and interpretations of these data;

offer, where possible, assistance to authors from all European Union countries in improving the impact and quality of national information on communicable diseases.

《Eurosurveillance》是一本由EUR CENTRE DIS PREVENTION & CONTROL出版商出版的专业医学期刊，该刊创刊于1995年，刊期Weekly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 2区，小类学科：传染病学 2区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖传染病学等领域，旨在及时、准确、全面地报道国内外传染病学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为21.286，平均审稿速度一般,3-8周。